Texas Retina Associates
Clinical trials sponsored by Texas Retina Associates, explained in plain language.
-
New combo therapy may cut need for frequent eye shots in macular degeneration
Disease control CompletedThis study tested whether adding a light-based treatment (photodynamic therapy) to the standard drug ranibizumab could reduce the number of eye injections needed for wet macular degeneration. Sixty adults over age 50 with the condition took part. The goal was to see if the combin…
Phase: PHASE2 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a combo eye treatment cut down on needle pokes?
Disease control CompletedThis study looked at whether adding a dexamethasone implant (Ozurdex) to standard bevacizumab (Avastin) eye injections could reduce the number of injections needed for people with non-ischemic central retinal vein occlusion. Sixty-eight participants received either Avastin plus a…
Phase: PHASE2, PHASE3 • Sponsor: Texas Retina Associates • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC